Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population
Authors
Keywords
PET, FSPG, HCC, Cancer imaging
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 18, Issue 6, Pages 924-934
Publisher
Springer Nature
Online
2016-09-27
DOI
10.1007/s11307-016-1007-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
- (2015) Anne Fages et al. BMC Medicine
- Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
- (2015) Rong Gao et al. Scientific Reports
- Hepatocellular Carcinoma and Gastroenteropancreatic Neuroendocrine Tumors: Potential Role of Other Positron Emission Tomography Radiotracers
- (2015) Hossein Jadvar SEMINARS IN NUCLEAR MEDICINE
- Metabolomics Study of Hepatocellular Carcinoma: Discovery and Validation of Serum Potential Biomarkers by Using Capillary Electrophoresis–Mass Spectrometry
- (2014) Jun Zeng et al. JOURNAL OF PROTEOME RESEARCH
- Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS
- (2014) Asem I. Fitian et al. LIVER INTERNATIONAL
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
- (2013) Q. Huang et al. CANCER RESEARCH
- 11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective
- (2013) T. T. Cheung et al. JOURNAL OF NUCLEAR MEDICINE
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC- Transporter Using Positron Emission Tomography in Patients with Non-Small Cell Lung or Breast Cancer
- (2012) S. Baek et al. CLINICAL CANCER RESEARCH
- (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate for Imaging of xC Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies
- (2012) S. Baek et al. JOURNAL OF NUCLEAR MEDICINE
- Specific PET Imaging of xC−Transporter Activity Using a18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism
- (2011) Norman Koglin et al. CLINICAL CANCER RESEARCH
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- CT and MRI Improve Detection of Hepatocellular Carcinoma, Compared With Ultrasound Alone, in Patients With Cirrhosis
- (2010) Nam C. Yu et al. Clinical Gastroenterology and Hepatology
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
- (2009) A. Sangiovanni et al. GUT
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- (2009) R. L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of lymph nodes with RECIST 1.1
- (2008) L.H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now